Completed PHASE1 INTERVENTIONAL 2-arm NCT05259995

Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance

Verification of Performance of Sustained Acoustic Medicine Device Designs Diathermy

Sponsor: ZetrOZ, Inc.

Conditions Measurement of Diathermy on Anatomical Locations of the Body

Interventions Sustained Acoustic Medicine

Updated 4 times since 2022 Last updated: Feb 17, 2023 Started: Feb 21, 2022 Primary completion: Jun 30, 2022 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05259995, this PHASE1 trial focuses on Measurement of Diathermy on Anatomical Locations of the Body and remains completed. Sponsored by ZetrOZ, Inc., it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Mar 2023 — Jul 2024 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Apr 2022 — Mar 2023 [monthly]

Recruiting PHASE1

First recorded

Feb 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ZetrOZ, Inc.

Data source: ZetrOZ, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Trumbull, United States